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Abstract In response to external amino acids, the permease-
like sensor Ssy1 of Saccharomyces cerevisiae activates a
pathway leading to transcriptional induction of several permease
genes including AGP1 and PTR2. We previously reported that
AGP1 induction requires Grr1, the F-box protein part of the
SCFGrr1 ubiquitin^ligase complex. We show here that ubiquitin,
other components of SCFGrr1 and the ubiquitin-conjugating
enzyme Cdc34 are essential for AGP1 and PTR2 induction. This
suggests that transduction to these genes of the amino acid signal
generated by Ssy1 involves an SCFGrr1-catalysed ubiquitination
step. ß 2001 Published by Elsevier Science B.V. on behalf of
the Federation of European Biochemical Societies.
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1. Introduction
Among the V270 yeast proteins classi¢ed as membrane
transporters [1^3], some are proposed to act as sensors of
external compounds. For instance, Snf3 and Rgt2 are similar
to hexose facilitators (Hxt proteins) but their main role is to
control transcription of HXT genes in response to external
glucose [4]. Unlike classical Hxt transporters, Snf3 and Rgt2
are expressed at low levels and they harbour a much larger
cytosolic C-terminal domain essential to their function as glu-
cose sensors [5]. A central component of the transduction
pathway activated by Snf3 and Rgt2 is the SCFGrr1 ubiqui-
tin^ligase complex [6]. This complex is best known for its role
in ubiquitination and degradation of cyclins Cln1 and Cln2
[7]. In the glucose signalling pathway, SCFGrr1 is proposed to
modulate, directly or indirectly, the activity of Rgt1, a Cys6-
Zn2 family transcription factor acting both as a repressor (low
glucose) and as an activator (high glucose) of HXT gene tran-
scription [8].
Another yeast permease-like sensor, Ssy1, is homologous to
amino acid permeases [9^11]. Ssy1 di¡ers from the latter pro-
teins by its much longer N-terminal tail (278 amino acids),
two larger extracellular loops connecting transmembrane do-
mains and a lower expression level [12]. Ssy1 is essential to
transcriptional induction in response to multiple amino acids
of the AGP1 gene encoding a broad-speci¢city amino acid
permease, of six other amino acid permease genes (BAP2,
BAP3, GNP1, BAP2, TAT1 and TAT2) and of the di-tri-pep-
tide permease gene PTR2 [9,10]. The large N-terminal tail of
Ssy1, factors Ptr3 and Ssy5 and transcription factor Uga35/
Dal81 are essential components of the Ssy1 transduction path-
way [10^13]. Furthermore, the F-box protein Grr1, essential
for transduction of the glucose signals generated by Snf3 and
Rgt2 [6], is also essential for induction by amino acids of the
AGP1 gene [10]. However, little is known about the exact role
of Grr1 in the amino acid signalling pathway.
In this paper we show that ubiquitin, other components of
the SCFGrr1 ubiquitin^ligase complex and the ubiquitin-con-
jugating enzyme Cdc34 are required for transcriptional induc-
tion in response to amino acids of the AGP1 and PTR2 genes.
This strongly suggests that the ubiquitination of a factor is
required for transduction to these genes of the amino acid
signal generated by Ssy1.
2. Materials and methods
2.1. Strains, growth conditions and methods
The Saccharomyces cerevisiae strains used in this study are all iso-
genic with the wild-type 41278b [14] except for the mutations men-
tioned (Table 1). Cells were grown in a minimal bu¡ered (pH 6.1)
medium with 3% glucose or galactose (when mentioned) as the carbon
source [15]. To this medium, urea (5 mM), proline (5 mM),
(NH4)2SO4 (10 mM), amino acids (1^10 mM), or combinations of
these compounds were added as a source(s) of nitrogen. Assays for
resistance to toxic amino acid analogues were carried out on plates
with (NH4)2SO4 (10 mM) as the sole nitrogen source. Analogue con-
centrations were as follows: 20 Wg/ml, L-(2-thienyl)-D,L-alanine; and
20 Wg/ml, D,L-ethionine. All procedures for manipulating DNA were
standard ones [16,17]. The Escherichia coli strain used was JM109.
2.2. L-Galactosidase assays
All L-galactosidase assays were performed on cells that reached the
state of balanced growth except for cells harvested at various times
after the addition of an amino acid in the culture medium. L-Galac-
tosidase assays were measured as described earlier [18] and are ex-
pressed as nmol of o-nitrophenol formed per min per mg of protein.
Protein concentrations were measured with the Folin reagent and
bovine serum albumin as the standard [19].
3. Results and discussion
3.1. Components of the SCFGrr1 ubiquitin^ligase complex are
required for induction of the AGP1 gene
Induction of AGP1 by amino acids requires Grr1 [10], the
F-box protein part of the SCFGrr1 ubiquitin^ligase complex
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[20]. Other components of SCFGrr1 include Cdc53, Skp1 and
the Ring-H2 ¢nger protein Hrt1 [20]. More recently, Sgt1 has
been identi¢ed as another component of SCFGrr1 [21]. Cdc34
is the ubiquitin-conjugating enzyme involved in all thus far
described SCF-mediated protein degradation processes. To
determine if Grr1 is required for AGP1 expression as a com-
ponent of the SCFGrr1 complex, we tested whether Cdc34 and
three other SCFGrr1 components besides Grr1 (Cdc53, Skp1,
Hrt1) are also required for AGP1-lacZ induction (Fig. 1A).
As expected, induction of AGP1-lacZ was totally impaired in
the grr1v strain. It was also strongly impaired in the cdc34-1,
skp1-12 and hrt1 thermosensitive mutants, suggesting that the
SCFGrr1 complex plays an important role in AGP1 induction.
Unexpectedly, induction of AGP1 was almost una¡ected in
the cdc53-1 mutant (Fig. 1A). Hence, either Cdc53 is not
involved in AGP1 induction, or the cdc53-1 mutation does
not impair the role of Cdc53 in AGP1 induction. It is note-
worthy that the cdc53-1 mutation used in this experiment like-
wise did not a¡ect another function involving all other com-
ponents of the SCF complex [22]. Other conditional alleles of
the CDC53 gene should thus be tested to assess the role of this
protein in AGP1 induction.
3.2. A normal pool of ubiquitin is essential to induction of
AGP1 expression
The important role of SCFGrr1 components and Cdc34 in
AGP1 induction suggests that transduction to this gene of the
amino acid signal generated by Ssy1 involves a ubiquitination
step. To assess the importance of ubiquitin in the Ssy1 path-
way, we monitored expression of the AGP1 gene in an npi2/
doa4 strain. The DOA4 gene encodes a ubiquitin hydrolase
important for recycling ubiquitin during protein degradation
by the proteasome [23]. In the npi2/doa4 strain used in this
Table 1
Yeast strains used in this study
Strain Genotype Reference or source
23344c MATK ura3 M. Grenson
30629c MATa gap1v : :kanMX2 ura3 [10]
32501d MATa gap1v : :kanMX2 ssy1v : :kanMX2 ura3 [10]
34277b MATa gap1v : :kanMX2 grr1v : :kanMX2 ura3 This study
27002d MATa npi2 ura3 [33]
27061b MATa trp1 [25]
27071b MATa trp1 npi2 [25]
JA115 MATK grr1v : :kanMX2 ura3 [10]
MT235 MATa his3-11, leu2-3, ura3-1, ade2-1, trp1-1, can1-100 M. Tyers
MT670 MATa his3-11, leu2-3, ura3-1, ade2-1, trp1-1, can1-100, cdc34-1 [34]
MT871 MATa his3-11, leu2-3, ura3-1, ade2-1, trp1-1, can1-100, cdc53-1 [34]
Y554 MATa his3-11, leu2-3, ura3-1, ade2-1, trp1-1, can1-100, skp1-12 [35]
HRT1-myc9 MATa can1-100, leu2-3, -112, his3-11,-15, trp1-1, ura3-1, ade2-1, pep4: :TRP1, bar1: :LEU2,
hrt1: :HRT1myc9-HIS5
[36]
6
Fig. 1. Induction of AGP1 (A) and PTR2 (B) are impaired in mu-
tants defective in components of the SCFGrr1 ubiquitin^ligase com-
plex. Yeast cells transformed with AGP1: :lacZ or PTR2: :lacZ re-
porter plasmid were pregrown at 30‡C to mid-log phase on urea
minimal medium. Cells were then shifted to 37‡C for 60 min before
isoleucine 5 mM was added to the media. Cell samples were taken
at the indicated time intervals and assayed for L-galactosidase activ-
ity. The strains bearing thermosensitive mutations (except for grr1v)
were MT235 (wild type, F), MT670 (cdc34-1, S), Y554 (skp1-12,
E), MT871 (cdc53-1, 8) HRT1 (HRT1myc9, P) and JA115 (grr1v,
O) transformed by plasmid YCpLEU2-HIS3 (pJYS20), YEpTRP1
(pFL45s) and YCpAGP1: :lacZ.
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study, the internal ubiquitin pool is reduced several-fold, and
this leads to impaired ubiquitination of many proteins [24,25].
The results show that induction of AGP1-lacZ expression is
severely impaired in the npi2/doa4 mutant (Table 2). To con-
¢rm that this e¡ect is due to a reduced ubiquitin pool, we
repeated the experiment using npi2/doa4 strains transformed
with a high-copy-number vector bearing the ubiquitin gene
(UBI1) under the control of the copper-inducible CUP1 pro-
moter. The results of the L-galactosidase assays show that
impairment of induced AGP1-lacZ expression in the npi2/
doa4 mutant is indeed largely relieved if the cells overproduce
ubiquitin (Table 2). As ubiquitin plays an important role in
many cellular functions including transcription, a control ex-
periment using ARO9-lacZ as the reporter gene was con-
ducted in parallel. The ARO9 gene encodes aromatic amino-
transferase II, the enzyme catalysing the ¢rst step of
tryptophan, phenylalanine and tyrosine catabolism. This
gene is induced by aromatic amino acids independently of
Ssy1 [26]. Whereas phenylalanine-triggered induction of
AGP1 expression was reduced V30-fold in the npi2/doa4
strain, that of ARO9 was reduced only V3-fold, an e¡ect
largely compensated by overproduction of ubiquitin (Table
2). It thus seems that ubiquitin plays a much more important
role in phenylalanine-triggered induction of AGP1 expression
than in phenylalanine-triggered induction of ARO9 expres-
sion. These results reinforce the view that ubiquitin plays an
important role in the Ssy1 transduction pathway.
The SCF complex is modi¢ed by attachment of Rub1/
Nedd8, a ubiquitin-like protein, to the Cdc53/Cullin subunit
[27]. This modi¢cation, observed in organisms ranging from
yeast to humans, appears to enhance the activity of the SCF
complex [27,28]. We monitored expression of the AGP1-lacZ
gene in rub1v cells but did not observe any signi¢cant change
(Table 3). Similarly Smt3, another ubiquitin-related protein,
does not seem to play an important role in AGP1 expression,
as judged by the lack of e¡ect of a thermosensitive smt3 mu-
tation [29] on expression of the AGP1-lacZ gene (data not
shown).
3.3. F-box protein Grr1p is involved in PTR2 expression and
utilisation of various amino acids
Lack of AGP1 expression in a gap1v mutant defective in
the general amino acid permease leads to very poor growth
when one of several amino acids, such as leucine, phenylala-
nine, or methionine, is supplied at low concentration (1 mM)
as the sole nitrogen source. Deletion of the SSY1 gene in the
same gap1 background has a broader e¡ect on amino acid
utilisation because this gene is required for induction of other
amino acid permease genes besides AGP1 [10]. As a ¢rst step
in investigating whether Grr1 is involved in expression of the
other amino acid permease genes under Ssy1 control, we com-
pared the growth phenotype of [gap1v agp1v], [gap1v ssy1v]
and [gap1v grr1v] strains (Fig. 2 and data not shown). The
[gap1v grr1v] mutant grew normally on NH4 medium, but it
failed to grow under conditions which a¡ected the growth of
the [gap1v ssy1v] strain. Furthermore, the [gap1v grr1v]
strain grew very slowly on a high concentration (10 mM) of
methionine, leucine, threonine, or phenylalanine, conditions
under which the [gap1v ssy1v] strain grew normally or nearly
so. Hence, Grr1 seems essential for expression of other amino
acid permease genes, in addition to AGP1, which are under
Ssy1 control. Furthermore, the fact that a Grr1 de¢ciency has
a broader impact spectrum than a Ssy1 de¢ciency suggests
that Grr1 is required for expression of amino acid utilisation
genes not under Ssy1 control. We then tested if a gene not
involved in amino acid uptake though under Ssy1 control, i.e.
the di-tri-peptide permease gene PTR2, requires Grr1 for in-
duction by amino acids. The results of experiments monitor-
ing expression of PTR2-lacZ indeed showed that PTR2-lacZ
remains uninduced in the grr1v strain (Table 3). We also
tested if other components of the SCFGrr1 complex are in-
volved in induction of PTR2 (Fig. 1B). We found that induc-
tion by tryptophan of PTR2-lacZ is impaired in skp1-12, hrt1
and cdc34-1 mutant strains. Interestingly, unlike what was
observed for AGP1-lacZ, induction of PTR2-lacZ was also
impaired in the cdc53-1 mutant (Fig. 1B). This suggests that
the mechanisms through which Cdc53 within the SCFGrr1
complex mediates induction of AGP1 and PTR2 are not
strictly the same. For instance, the target protein of SCFGrr1
Table 2
A normal pool of ubiquitin is required for induced transcription of
AGP1 gene
L-Galactosidase activity (nmol/min/mg of protein)
AGP1-lacZ ARO9-lacZ
3Ub +Ub 3Ub +Ub
^ Phe ^ Phe ^ Phe ^ Phe
Wild type 9 609 12 403 2 955 5 891
npi2/doa4 4 18 12 324 5 261 5 637
Strains 27061b (trp1, ura3) and 27071b (trp1, ura3, npi23) were
transformed by the CEN-based plasmid YCpAGP1-lacZ or YCp-
ARO9-lacZ and pFL39 (3Ub) or YEp96 (+Ub) plasmids. YEp96
contains a synthetic yeast Ub gene under the control of the copper-
inducible CUP1 promoter [37]. Cells were grown on minimal me-
dium with urea as the sole nitrogen source, then CuSO4 (1 mM)
was added to the culture to induce overproduction of ubiquitin.
After 2 h of induction, phenylalanine was added at 5 mM ¢nal con-
centration. Cells where harvested at time 0 of induction by phenyl-
alanine and after 3 h. The reported L-galactosidase activities are
means of two to three independent experiments. Variations were less
than 20%.
Table 3
The Grr1 protein is required for induced transcription in response to multiple amino acids of AGP1 and PTR2 genes
Line no. L-Galactosidase activity (nmol/min/mg of protein)
AGP1-lacZ PTR2-lacZ
^ Leu Met Trp ^ Leu Met Trp
1 wild type 9 2 1036 933 1577 4 35 37 89
2 grr1v 9 2 9 2 9 2 12 5 4 4 4
3 rub1v 9 2 980 1181 1657 n.d. n.d. n.d. n.d.
Strains 23344c (ura3), JA115 (grr1v) and JA170 (rub1v) transformed by the CEN-based plasmid YCpAGP1-lacZ or YCpPTR2-lacZ plasmid
were grown on minimal urea medium with the added indicated compounds at 5 mM ¢nal concentration. The reported L-galactosidase activities
are means of two to three independent experiments. Variations were less than 20%. n.d.: not determined.
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in induction of each gene could be di¡erent. Alternatively,
SCFGrr1 could act in the context of gene promoters [30] whose
constraints for gene activation might be di¡erent for both
genes. A striking feature of PTR2 expression is that it is
regulated by two di¡erent ubiquitin ligases, namely Ubr1
and the SCFGrr1 complex. The ¢rst is involved in the intra-
cellular peptide induction pathway (Ubr1/Cup9) [31] and the
second in the extracellular amino acid induction pathway
(Ssy1/Ptr3/Ssy5/SCFGrr1) (Fig. 1B).
In conclusion, these results support the idea that SCFGrr1
complex and ubiquitin play an important role in the external
amino acid signalling pathway. However, their precise role
remains to be determined. Possibly, expression of Ssy1 target
genes is prevented when some factor is not degraded via the
SCFGrr1 ubiquitin pathway. The factor might be a negative
component of the signalling pathway, or a positive component
that needs to undergo ubiquitin-dependent processing to be
activated in response to amino acids. Another possibility is
that the Ssy1 pathway does not include any ubiquitination
step and that the factor accumulating in ubiquitin hydrolase
or SCF components mutants is part of another transcriptional
control mechanism acting in a dominant negative fashion on
genes controlled by Ssy1p. This would imply that induction of
Ssy1p-regulated genes by external amino acids depends both
on activation of the Ssy1 pathway and on SCFGrr1-dependent
relief from a negative control mechanism in response to un-
known signals. The genetic analysis of suppressors of grr1
mutations should help to unravel the exact roles of SCFGrr1
and ubiquitin in transcription of amino acid and peptide per-
mease genes.
Remarkably, the components of the SCFGrr1 complex are
also required for expression of the HXT genes regulated by
the Snf3 and Rgt2 glucose sensors [6]. Since a mutation in
CDC34 was found not to a¡ect induction of the HXT genes, it
could be that another ubiquitin-conjugating enzyme is in-
volved [8]. As in the Ssy1 pathway, the protein targets of
SCFGrr1 pathway in the glucose signalling remain unknown
[6]. The SCFGrr1 complex is best known for its role in the
degradation of cyclins Cln1 and Cln2 [7,28] and of Gic1
and Gic2, two proteins regulating actin polymerisation and
bud emergence [32]. An unanswered key question is whether
the role of SCFGrr1 in control of glucose and amino acid
transport is coupled to its involvement in cell cycle regulation.
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